TMCnet News
Novelos Therapeutics Up 50% Since SmarTrend's Buy RecommendationDec 21, 2009 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for Novelos Therapeutics (NASDAQ:NVLT) on August 04, 2009 at $0.82. In roughly 5 months, Novelos Therapeutics has returned 50% as of today's recent price of $1.23. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com. Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html [ Back To TMCnet.com's Homepage ] |